Company profile
CuraScientific Corp
OTC: CSTF · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ Coachella, OKCIK 0001877788Reports USD
#1106 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ 12GM —SS 40
v0.1 · 25/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ workforce scale, balance-sheet leverage
Methodology →Revenue TTM
$671.7k
Rev growth YoY (TTM)
+954.6%
Net income (FY)
-$5.3M
Employees
2
as of 2026-08-27
Market cap
$377.3k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$34.4k$34.4k2022
Net income-$5.3M-$5.3M2022
Operating income-$2.4M-$2.4M2022
Total assets$1.6M$1.6M2022
Liabilities$71.1M$71.1M2022
Equity-$69.5M-$69.5M2022
Revenue trend
FY2021 – FY2022 · USD
FY21
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is CuraScientific Corp’s revenue?
CuraScientific Corp booked $34.4k in FY2022 revenue, contracting 60% year over year — slower than 84% of Healthcare companies we track, at a -15299.2% net margin.
Peers · Healthcare
NanoLogix, Inc.——Mountain Valley MD Holdings Inc.——Cognetivity Neurosciences Ltd.——Impact BioMedical Inc.32DenVVeno Medical Corporation40DBioasis Technologies Inc.——Key facts
CEOSamuel L. Berry
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersCoachella, OK
ExchangeOTC: CSTF
Employees2
IPO date1998-01-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.